dexamethasone,lenalidomide,bortezomib
takeda
['determination', 'mmsm']
#asco22 final plenary-determination study evaluating timing of sct in ndmm. pfs still better with early sct, no os difference with almost 76 mo f/u. only 28% had sct at relapse. qol reduced during sct; more subgroup data needed #mmsm #myeloma 
CME experts Sara Fagerlie, PhD, CHCP and Mindy Tanzola, PhD founded Front Row CME to help clinicians and educators manage the oncology information deluge.